SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE for SUSAN G. KOMEN FOR THE CURE ADVOCACY ALLIANCE
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of Pub. Law No. 111-148, the Patient Protection and Affordable Care Act, primarily patient protection provisions, provisions on breast health education and postal provision. (Continued on Addendum) H.R.3070/S.1599, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2012, primarily matters related to appropriations for cancer research and cancer screening programs. H.R.2219, Department of Defense Appropriations Act, 2012, primarily matters related to appropriations for Congressional Directed Medical Research Programs. Pub. Law No. 112-25, the Budget Control Act of 2011, primarily matters related to funding of cancer research and breast cancer programs. H.R.466/S. 384, Breast Cancer Research Stamp Reauthorization Act. H.R.2245/S.296, Preserving Access to Life-Saving Medications Act of 2011, primarily matters related to cancer treatments. H.R.2499, Lymphedema Diagnosis and Treatment Cost-Saving Act of 2011. H.R.3613, Part D Beneficiary Appeals Fairness Act, primarily matters related to specialty tiers of prescription drugs. H.R.3102, Breast Density and Mammography Reporting Act of 2011. H.R.3067, Accelerating the End of Breast Cancer Act of 2011. H.R.3705, Comprehensive Cancer Care Improvement Act of 2011. H.R.2746, Cancer Drug Coverage Parity Act of 2011. H.R.111, Breast Cancer Patient Protection Act of 2011.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALLISON COHEN | — |
| KAREN HANDEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.